ALL THE TOOLS

ANTIPSYCHOTICS' RISK MEASUREMENT IN EUROPE

ANTIPSYCHOTICS' RISK REDUCTION IN EUROPE

  TIMELY DIAGNOSIS & ANTIPSYCHOTICS   ETHICS IN PRACTICE & ANTIPSYCHOTICS

Being chronically exposed to antipsychotics in Alzheimer's disease leads to increased severe side effects risk; it is crucial to measure & monitor this risk

Different strategies have been implemented in Europe to limit the prescription of antipsychotics & then the risk of exposure in dementia

The diagnosis of the disease could be an opportunity to plan the prevention of the overuse of antipsychotics

The use of AP must be analyzed from several ethical perspectives: e.g. distinguishing situations where AP are used in response to particular symptoms & where they are used as a form of restraint (as an alternative to physical restraint)

Risk Exposure in Europe
European Projects
Recommendations & Tools
Risk reduction in Europe
ALCOVE survey results
European Projects
The UK Call for Action
The French AMI Alzheimer programme
Recommendations & Tools
Diagnosis, BPSD & Antipsychotics
Evidence-based projects
Early Intervention Services
Dementia Adviser Services
Early Interventions
Family Interventions
Recommendations & Tools
Ethical aspects of the use of antipsychotics in dementia
What do we know about AP & competence assessment?
Key points & Tools

To know more

To know more

To know more

To know more

BEHAVIOURAL & PSYCHOLOGICAL SYMPTOMS OF DEMENTIA
Support Systems for Behavioural & Psychological Symptoms of Dementia (BPSD) Rationale
(1) Structures & Care organisations (SCO), (2) Individualised Patient & Family Carers Interventions (IPCI), (3) Workforce – Skills (WFS)
STRUCTURES & CARE ORGANISATIONS INDIVIDUALIZED PATIENT & FAMILY CARER INTERVENTIONS (IPCI), the 2nd dimension of Support Systems for BPSD in dementia WORKFORCE - SKILLS

What types of structures & organisations of care are dedicated to BPSD?

What are the psychosocial interventions & the non pharmacological therapies delivered in the different support systems?

How are professionals educated for BPSD knowledge, prevention & management, particularly regarding antipsychotics?

Definitions & Pathways
ALCOVE survey in Europe
Recommendations & Indicators
Summary of evidence on
Psychosocial interventions for BPSD
Non pharmacological therapies for BPSD
Pharmacological interventions
ALCOVE survey in Europe on programmes for family carers
Recommendations & Tools
ALCOVE survey on clinical guidelines & education in Europe
Recommendations & Tools

To know more

To know more

To know more

EUROPEAN PROJECTS TO PREVENT & MANAGE BPSD
 

<< Back